S. Koreans Report New Drug To Suppress Key Liver Cancer Protein
This article was originally published in PharmAsia News
Executive Summary
South Korean researchers say they have developed a treatment capable of suppressing the protein behind much liver cancer. A published study said the TSAHC treatment is aimed at TM4SF5, the protein already known to be a major cause of the cancer. The substance, which is about to enter clinical trials in South Korea and the United States, has shown to have fewer side effects than drugs already available. (Click here for more